期刊文献+

影响胃癌术后患者预后的临床及病理因素 被引量:4

下载PDF
导出
摘要 胃癌是常见消化系统肿瘤,手术是胃癌主要的治疗手段,我国胃癌5年生存率35.1%[1],总体生存率低,有必要对胃癌术后预后进行预测,从而降低复发率,提高生存率。常用恶性肿瘤预后因素包括:生存率、死亡率、并发症、复发率等指标。影响胃癌根治术后预后因素较多,目前主要影响预后因素仍然集中在临床(手术、是否辅助治疗、分子分型等)及病理因素,我们将从临床、病理因素作综述。
作者 杜泽东 李秋
出处 《四川医学》 CAS 2018年第12期1420-1424,共5页 Sichuan Medical Journal
基金 四川省卫生和计划生育委员会科研课题(编号:18PJ195) 成都市卫生和计划生育委员会科研课题(编号:2018079)
  • 相关文献

参考文献1

二级参考文献21

  • 1Guan Zhen Yu,Ying Chen,Jie Jun Wang.Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance[J].Journal of Cancer Research and Clinical Oncology.2009(10)
  • 2Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 3Andreas H. Marx,Lars Tharun,Johanna Muth,Ana-Maria Dancau,Ronald Simon,Emre Yekebas,Jussuf T. Kaifi,Martina Mirlacher,Tim H. Brümmendorf,Carsten Bokemeyer,Jakob R. Izbicki,Guido Sauter.HER-2 amplification is highly homogenous in gastric cancer[J]. Human Pathology . 2009 (6)
  • 4HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing[J]. Virchows Archiv . 2010 (3)
  • 5Carol E. DeSantis,Chun Chieh Lin,Angela B. Mariotto,Rebecca L. Siegel,Kevin D. Stein,Joan L. Kramer,Rick Alteri,Anthony S. Robbins,Ahmedin Jemal.Cancer treatment and survivorship statistics, 2014[J]. CA: A Cancer Journal for Clinicians . 2014 (4)
  • 6I. García,F. Vizoso,A. Martín,L. Sanz,O. Abdel-Lah,P. Raigoso,J. L. García-Mu?iz.Clinical Significance of the Epidermal Growth Factor Receptor and HER2 Receptor in Resectable Gastric Cancer[J]. Annals of Surgical Oncology . 2003 (3)
  • 7Stephen B. Edge,Carolyn C. Compton.The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM[J]. Annals of Surgical Oncology . 2010 (6)
  • 8Tomonori Yano,Toshihiko Doi,Atsushi Ohtsu,Narikazu Boku,Kaoru Hashizume,Mamoru Nakanishi,Atsushi Ochiai.??Comparison of HER2 gene amplification assessed by fluorescence in situhybridization and HER2 protein expression assessed by immunohistochemistry ingastric cancer(J)Oncology Reports . 2006 (1)
  • 9Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.??HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series(J)Cellular Oncology . 2010 (1-2)
  • 10Dong Il Park,Jung Won Yun,Jung Ho Park,Suk Joong Oh,Hong Joo Kim,Yong Kyun Cho,Chong Il Sohn,Woo Kyu Jeon,Byung Ik Kim,Chang Hak Yoo,Byung Ho Son,Eun Yoon Cho,Seoung Wan Chae,Eo-Jin Kim,Jin Hee Sohn,Seung Ho Ryu,Antonia R. Sepulveda.??HER-2 / neu Amplification Is an Independent Prognostic Factor in Gastric Cancer(J)Digestive Diseases and Sciences . 2006 (8)

共引文献7

同被引文献40

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部